Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Part of paid clinical trials in Newport Beach, California.

Sponsor
Indiana University
Study ID
NCT07676565
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

Key Dates

Start date
Mar 24, 2026
Status verified
Jun 2026
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Change in HbA1c by type of therapy [ Time Frame: 1 year ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Hoag Memorial HospitalNewport BeachCalifornia92663
Brittany Dennis
949-764-6896
David Ahn, MD (PRINCIPAL_INVESTIGATOR)
Emory UniversityAtlantaGeorgia30303
sabeena usman
404-251-8959
Francisco Pasquel, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Evelyn Fronczyk
312-908-9002
Grazia Aleppo, MD (PRINCIPAL_INVESTIGATOR)
Maine Health Research InstitutePortlandMaine04102
Debra Burris
207-662-2467
Jay Ambalavanan, MD (PRINCIPAL_INVESTIGATOR)
Harvard Medical SchoolBostonMassachusetts02115
Grace Ordonez
617-732-4245
Zeb Saeed, MD (PRINCIPAL_INVESTIGATOR)
Henry Ford HospitalDetroitMichigan48202
Lydia Oehring
313-916-3906
Davida Kruger, ANP (PRINCIPAL_INVESTIGATOR)
Mount SinaiNew YorkNew York10029
Sophie Baun
212-241-4301
Carol Levy, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Newport Beach, CA

By condition
By specialty

Related Studies